INTECH Investment Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$373K	Buy	24,945 +4,517	+22%	+$67.6K	﹤0.01%	1764
2025 Q1	$330K	Buy	20,428 +6,385	+45%	+$103K	﹤0.01%	1828
2024 Q4	$327K	Buy	14,043 +5,672	+68%	+$132K	﹤0.01%	1792
2024 Q3	$246K	Buy	+8,371	New	+$246K	﹤0.01%	1622